Related Experiment Video
Updated: Dec 24, 2025

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
Published on: January 12, 2015
Embryonic stem cells prevent developmental cardiac defects in mice
Diego Fraidenraich1, Robert Benezra
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. fraidend@mskcc.org
Abstract:
The potential therapeutic use of embryonic stem cells (ESCs) has gathered the attention of the scientific and medical communities recently. We report that in addition to their unique capacity to populate defective cardiac tissues, ESCs secrete factors that correct gene expression profiles in the defective neighboring cells. Id (inhibitor of DNA binding) gene knockout (KO) mouse embryos die at midgestation because of multiple cardiac defects, but injection of ESCs into preimplantation Id KO embryos prevents these defects and corrects gene expression profiles throughout the heart. ESCs injected into expectant mothers only partially rescue cardiac defects in the Id KO embryos. Two secreted factors are implicated in the rescue process: insulin-like growth factor I accounts for the long-range action of the ESCs, and Wnt5a, a short-range factor, corrects gene expression profiles in the Id KO hearts. Future studies are discussed.
Insights
Embryonic stem cells (ESCs) not only repair heart tissue but also secrete factors that correct gene expression in surrounding cells. This study shows ESCs can prevent and correct cardiac defects in Id knockout mouse embryos.
Area of Science:
- Stem cell biology
- Developmental biology
- Cardiovascular research
Background:
- Embryonic stem cells (ESCs) show therapeutic potential for tissue repair.
- Cardiac defects in Id (inhibitor of DNA binding) gene knockout (KO) mouse embryos are lethal.
- Understanding ESCs' paracrine effects is crucial for regenerative medicine.
Purpose of the Study:
- To investigate the therapeutic potential of ESCs in correcting cardiac defects.
- To identify the secreted factors responsible for ESC-mediated cardiac repair.
- To elucidate the mechanisms by which ESCs influence gene expression in defective tissues.
Main Methods:
- Injection of ESCs into preimplantation Id KO mouse embryos.
- Analysis of cardiac morphology and gene expression profiles in treated embryos.
- Identification of secreted factors using biochemical assays.
Main Results:
- ESC injection into preimplantation embryos fully prevented cardiac defects and corrected gene expression in Id KO hearts.
- ESC injection into expectant mothers only partially rescued cardiac defects.
- Insulin-like growth factor I and Wnt5a were identified as key secreted factors mediating long-range and short-range effects, respectively.
Conclusions:
- ESCs possess a dual capacity to repopulate damaged tissue and secrete factors that correct cellular gene expression.
- Secreted factors like IGF-I and Wnt5a play critical roles in ESC-mediated cardiac repair.
- This research highlights novel therapeutic strategies for congenital heart defects using ESC-derived factors.
More Related Videos
10:46Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: November 3, 2011
08:08Modified Mouse Embryonic Stem Cell based Assay for Quantifying Cardiogenic Induction Efficiency
Published on: April 22, 2011
Related Concept Videos
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...